91制片厂

Published on Market Research Reports庐 Inc. ()

Home > C-Reactive Protein Rapid Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

C-Reactive Protein Rapid Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID: 
PB509242490
Publication Date: 
September 19, 2024
Pages: 
115
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 3,950.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

C-Reactive Protein Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of human C-reactive protein (CRP) in whole blood, serum, and plasma samples.
The global market for C-Reactive Protein Rapid Test was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for C-Reactive Protein Rapid Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for C-Reactive Protein Rapid Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for C-Reactive Protein Rapid Test was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of C-Reactive Protein Rapid Test include HORIBA Ltd., Thermo Fisher Scientific, Inc., F Hoffmann-La Roche Ltd., Quest Diagnostics, Abbott, Siemens Healthineers, Danaher, Ortho Clinical Diagnostics and Laboratory Corporation of America Holdings, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for C-Reactive Protein Rapid Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of C-Reactive Protein Rapid Test by region & country, by Type, and by Application.
The C-Reactive Protein Rapid Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C-Reactive Protein Rapid Test.
Market Segmentation
By Company
HORIBA Ltd.
Thermo Fisher Scientific, Inc.
F Hoffmann-La Roche Ltd.
Quest Diagnostics
Abbott
Siemens Healthineers
Danaher
Ortho Clinical Diagnostics
Laboratory Corporation of America Holdings
Merck & Co., Inc.
Segment by Type:
Immunoturbidimetric Assay
ELISA
Chemiluminescence immunoassay (CLIA)
Others
Segment by Application
Clinics
Hospitals
Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of C-Reactive Protein Rapid Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of C-Reactive Protein Rapid Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of C-Reactive Protein Rapid Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Market Overview
1.1 C-Reactive Protein Rapid Test Product Introduction
1.2 Global C-Reactive Protein Rapid Test Market Size Forecast
1.3 C-Reactive Protein Rapid Test Market Trends & Drivers
1.3.1 C-Reactive Protein Rapid Test Industry Trends
1.3.2 C-Reactive Protein Rapid Test Market Drivers & Opportunity
1.3.3 C-Reactive Protein Rapid Test Market Challenges
1.3.4 C-Reactive Protein Rapid Test Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global C-Reactive Protein Rapid Test Players Revenue Ranking (2023)
2.2 Global C-Reactive Protein Rapid Test Revenue by Company (2019-2024)
2.3 Key Companies C-Reactive Protein Rapid Test Manufacturing Base Distribution and Headquarters
2.4 Key Companies C-Reactive Protein Rapid Test Product Offered
2.5 Key Companies Time to Begin Mass Production of C-Reactive Protein Rapid Test
2.6 C-Reactive Protein Rapid Test Market Competitive Analysis
2.6.1 C-Reactive Protein Rapid Test Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by C-Reactive Protein Rapid Test Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C-Reactive Protein Rapid Test as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunoturbidimetric Assay
3.1.2 ELISA
3.1.3 Chemiluminescence immunoassay (CLIA)
3.1.4 Others
3.2 Global C-Reactive Protein Rapid Test Sales Value by Type
3.2.1 Global C-Reactive Protein Rapid Test Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global C-Reactive Protein Rapid Test Sales Value, by Type (2019-2030)
3.2.3 Global C-Reactive Protein Rapid Test Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Laboratories
4.2 Global C-Reactive Protein Rapid Test Sales Value by Application
4.2.1 Global C-Reactive Protein Rapid Test Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global C-Reactive Protein Rapid Test Sales Value, by Application (2019-2030)
4.2.3 Global C-Reactive Protein Rapid Test Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global C-Reactive Protein Rapid Test Sales Value by Region
5.1.1 Global C-Reactive Protein Rapid Test Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global C-Reactive Protein Rapid Test Sales Value by Region (2019-2024)
5.1.3 Global C-Reactive Protein Rapid Test Sales Value by Region (2025-2030)
5.1.4 Global C-Reactive Protein Rapid Test Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America C-Reactive Protein Rapid Test Sales Value, 2019-2030
5.2.2 North America C-Reactive Protein Rapid Test Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe C-Reactive Protein Rapid Test Sales Value, 2019-2030
5.3.2 Europe C-Reactive Protein Rapid Test Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific C-Reactive Protein Rapid Test Sales Value, 2019-2030
5.4.2 Asia Pacific C-Reactive Protein Rapid Test Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America C-Reactive Protein Rapid Test Sales Value, 2019-2030
5.5.2 South America C-Reactive Protein Rapid Test Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa C-Reactive Protein Rapid Test Sales Value, 2019-2030
5.6.2 Middle East & Africa C-Reactive Protein Rapid Test Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions C-Reactive Protein Rapid Test Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions C-Reactive Protein Rapid Test Sales Value
6.3 United States
6.3.1 United States C-Reactive Protein Rapid Test Sales Value, 2019-2030
6.3.2 United States C-Reactive Protein Rapid Test Sales Value by Type (%), 2023 VS 2030
6.3.3 United States C-Reactive Protein Rapid Test Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe C-Reactive Protein Rapid Test Sales Value, 2019-2030
6.4.2 Europe C-Reactive Protein Rapid Test Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe C-Reactive Protein Rapid Test Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China C-Reactive Protein Rapid Test Sales Value, 2019-2030
6.5.2 China C-Reactive Protein Rapid Test Sales Value by Type (%), 2023 VS 2030
6.5.3 China C-Reactive Protein Rapid Test Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan C-Reactive Protein Rapid Test Sales Value, 2019-2030
6.6.2 Japan C-Reactive Protein Rapid Test Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan C-Reactive Protein Rapid Test Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea C-Reactive Protein Rapid Test Sales Value, 2019-2030
6.7.2 South Korea C-Reactive Protein Rapid Test Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea C-Reactive Protein Rapid Test Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia C-Reactive Protein Rapid Test Sales Value, 2019-2030
6.8.2 Southeast Asia C-Reactive Protein Rapid Test Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia C-Reactive Protein Rapid Test Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India C-Reactive Protein Rapid Test Sales Value, 2019-2030
6.9.2 India C-Reactive Protein Rapid Test Sales Value by Type (%), 2023 VS 2030
6.9.3 India C-Reactive Protein Rapid Test Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 HORIBA Ltd.
7.1.1 HORIBA Ltd. Profile
7.1.2 HORIBA Ltd. Main Business
7.1.3 HORIBA Ltd. C-Reactive Protein Rapid Test Products, Services and Solutions
7.1.4 HORIBA Ltd. C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.1.5 HORIBA Ltd. Recent Developments
7.2 Thermo Fisher Scientific, Inc.
7.2.1 Thermo Fisher Scientific, Inc. Profile
7.2.2 Thermo Fisher Scientific, Inc. Main Business
7.2.3 Thermo Fisher Scientific, Inc. C-Reactive Protein Rapid Test Products, Services and Solutions
7.2.4 Thermo Fisher Scientific, Inc. C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific, Inc. Recent Developments
7.3 F Hoffmann-La Roche Ltd.
7.3.1 F Hoffmann-La Roche Ltd. Profile
7.3.2 F Hoffmann-La Roche Ltd. Main Business
7.3.3 F Hoffmann-La Roche Ltd. C-Reactive Protein Rapid Test Products, Services and Solutions
7.3.4 F Hoffmann-La Roche Ltd. C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.3.5 Quest Diagnostics Recent Developments
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Profile
7.4.2 Quest Diagnostics Main Business
7.4.3 Quest Diagnostics C-Reactive Protein Rapid Test Products, Services and Solutions
7.4.4 Quest Diagnostics C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.4.5 Quest Diagnostics Recent Developments
7.5 Abbott
7.5.1 Abbott Profile
7.5.2 Abbott Main Business
7.5.3 Abbott C-Reactive Protein Rapid Test Products, Services and Solutions
7.5.4 Abbott C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.5.5 Abbott Recent Developments
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Profile
7.6.2 Siemens Healthineers Main Business
7.6.3 Siemens Healthineers C-Reactive Protein Rapid Test Products, Services and Solutions
7.6.4 Siemens Healthineers C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.6.5 Siemens Healthineers Recent Developments
7.7 Danaher
7.7.1 Danaher Profile
7.7.2 Danaher Main Business
7.7.3 Danaher C-Reactive Protein Rapid Test Products, Services and Solutions
7.7.4 Danaher C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.7.5 Danaher Recent Developments
7.8 Ortho Clinical Diagnostics
7.8.1 Ortho Clinical Diagnostics Profile
7.8.2 Ortho Clinical Diagnostics Main Business
7.8.3 Ortho Clinical Diagnostics C-Reactive Protein Rapid Test Products, Services and Solutions
7.8.4 Ortho Clinical Diagnostics C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.8.5 Ortho Clinical Diagnostics Recent Developments
7.9 Laboratory Corporation of America Holdings
7.9.1 Laboratory Corporation of America Holdings Profile
7.9.2 Laboratory Corporation of America Holdings Main Business
7.9.3 Laboratory Corporation of America Holdings C-Reactive Protein Rapid Test Products, Services and Solutions
7.9.4 Laboratory Corporation of America Holdings C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.9.5 Laboratory Corporation of America Holdings Recent Developments
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Profile
7.10.2 Merck & Co., Inc. Main Business
7.10.3 Merck & Co., Inc. C-Reactive Protein Rapid Test Products, Services and Solutions
7.10.4 Merck & Co., Inc. C-Reactive Protein Rapid Test Revenue (US$ Million) & (2019-2024)
7.10.5 Merck & Co., Inc. Recent Developments
8 Industry Chain Analysis
8.1 C-Reactive Protein Rapid Test Industrial Chain
8.2 C-Reactive Protein Rapid Test Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 C-Reactive Protein Rapid Test Sales Model
8.5.2 Sales Channel
8.5.3 C-Reactive Protein Rapid Test Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned: 

HORIBA Ltd.
Thermo Fisher Scientific, Inc.
F Hoffmann-La Roche Ltd.
Quest Diagnostics
Abbott
Siemens Healthineers
Danaher
Ortho Clinical Diagnostics
Laboratory Corporation of America Holdings
Merck & Co., Inc.

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/c-reactive-protein-rapid-test-global-market-share-and-ranking-overall-sales-and-demand

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare